Riskpilot← Back to searchSign inGet full accessTranehälsan AB
ABActiveOrg 5591017354Storgatan 4General medical practice activities · NACE 8621Est. 201720 employees
Revenue 2025
SEK 34,6M
+11% vs 2024
EBITDA margin
16.9%
+418% vs 2024
Equity ratio
59.1%
Financial strength
Net profit 2025
SEK 4,5M
+514% vs 2024
| Revenue | SEK 34,6M | +11% |
| EBITDA | SEK 5,8M | +418% |
| Net profit | SEK 4,5M | +514% |
| Total assets | SEK 7,9M | -13% |
| Equity | SEK 4,7M | -9% |
| Employees | 20 | — |
Legal name
Tranehälsan AB
Org number
5591017354
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 februari 2017
Share capital
SEK 180 000
Employees
20 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall tillhandahålla vårdtjänster samt därmed förenlig verksamhet.
Address
Storgatan 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 23 726 | 26 833 | 29 873 | 31 043 | 34 575 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 5 566 | 5 300 | 3 695 | 1 126 | 5 828 |
| Depreciation & amort. | −136 | −154 | −185 | −223 | −241 |
| EBIT | 5 430 | 5 146 | 3 510 | 903 | 5 587 |
| Net financials | −7 | −7 | −4 | 15 | 18 |
| Profit before tax | 4 054 | 7 658 | 3 520 | 941 | 5 654 |
| Tax | −875 | −1 610 | −730 | −211 | −1 171 |
| Net profit | 3 179 | 6 048 | 2 790 | 730 | 4 483 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 11 054 | 13 598 | 11 270 | 9 070 | 7 901 |
| Equity | 4 342 | 8 515 | 7 405 | 5 135 | 4 668 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 939 | 4 830 | 3 626 | 3 720 | 3 067 |
| Total debt | 3 939 | 4 830 | 3 626 | 3 720 | 3 067 |
EBITDA margin
16.9%
This company
15.8%
Market median
+7% vs market
20212025
Equity ratio
59.1%
This company
38.2%
Market median
+55% vs market
20212025
Return on equity
96.0%
This company
18.4%
Market median
+422% vs market
20212025
Net profit margin
13.0%
This company
8.1%
Market median
+60% vs market
20212025
Asset turnover
4.38×
This company
1.12×
Market median
+291% vs market
20212025
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-07-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tranehälsan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl-Peter Bertil Kalle Wrane | Audit | 0 companies |
| Maria Jeanette Terése Georgsson | Board of Directors | 0 companies |
| Christine Edvinsson | Board of Directors | 0 companies |
| Erling Ulrik Edvinsson | Chairman | 0 companies |
| Lena Elisabet Byäng | Board of Directors | 0 companies |